The Development of Small Animal Models for Zika Virus Vaccine Efficacy Testing and Pathological Assessment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs.The American journal of tropical medicine and hygiene · 2018
   Article
2. Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice.PLoS neglected tropical diseases · 2017
   Article
3. A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model.NPJ vaccines · 2017
   Article
4. Advances in Diagnosis, Surveillance, and Monitoring of Zika Virus: An Update.Frontiers in microbiology · 2017
   Review

Corrections and comments

• Comment on
  Characterization of a Novel Murine Model to Study Zika Virus.2016

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as